Chung-Wai Shiau

From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors

Jiuxiang Zhu, Jui-Wen Huang, Ping‐Hui Tseng et al. · Cancer Research · 2004 · 256 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15

Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Functions Independently of PPARγ

Chung-Wai Shiau, Chih-Cheng Yang, Samuel K. Kulp et al. · Cancer Research · 2005 · 216 citations

Medicine, Oncology, Pharmacology +16

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3

Kuen‐Feng Chen, Wei‐Tien Tai, Tsung‐Hao Liu et al. · Clinical Cancer Research · 2010 · 170 citations

Life Sciences, Oncology, Pharmacology +17

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma

Wei‐Tien Tai, Ann‐Lii Cheng, Chung-Wai Shiau et al. · Journal of Hepatology · 2011 · 157 citations

Life Sciences, Molecular Biology, Oncology +17

Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy

Pei‐Feng Liu, Kun-Lin Tsai, Chien‐Jen Hsu et al. · Theranostics · 2017 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17